The Emerging Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Patients with HFpEF

Jessica Webb; Lauren Fovargue; Kristin Tøndel; Bradley Porter; Benjamin Sieniewicz; Justin Gould; Christopher Aldo Rinaldi; Tevfik Ismail; Amedeo Chiribiri; Gerald Carr-White

doi:10.1007/s11897-018-0372-1

The Emerging Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Patients with HFpEF

Jessica Webb, Lauren Fovargue, Kristin Tøndel, Bradley Porter, Benjamin Sieniewicz, Justin Gould, Christopher Aldo Rinaldi, Tevfik Ismail, Amedeo Chiribiri, Gerald Carr-White

GSTT Guy's and St Thomas' NHS Foundation Trust
Division of Imaging Sciences and Biomedical Engineering, King's College London, London, SE1 7EH, UK. [email protected].
Division of Imaging Sciences and Biomedical Engineering, King's College London, St Thomas Hospital, London SE1 7EH, UK [email protected].
Department of Mathematical Sciences and Technology, Centre for Integrative Genetics, Norwegian University of Life Sciences, P.O. Box 5003, N-1432 Ås, Norway.

Research output: Contribution to journal › Review article › peer-review

37 Citations (Scopus)

257 Downloads (Pure)

Abstract

PURPOSE OF REVIEW: To give an update on the emerging role of cardiac magnetic resonance imaging in the evaluation of patients with heart failure with preserved ejection fraction (HFpEF). This is important as the diagnosis of HFpEF remains challenging and cardiac imaging is pivotal in establishing the function of the heart and whether there is evidence of structural heart disease or diastolic dysfunction. Echocardiography is widely available, although the gold standard in quantifying heart function is cardiac magnetic resonance (CMR) imaging.

RECENT FINDINGS: This review includes the recently updated 2016 European Society of Cardiology guidelines on diagnosing HFpEF that define the central role of imaging in identifying patients with HFpEF. Moreover, it includes the pathophysiology in HFpEF, how CMR works, and details current CMR techniques used to assess structural heart disease and diastolic function. Furthermore, it highlights promising research techniques that over the next few years may become more used in identifying these patients. CMR has an emerging role in establishing the diagnosis of HFpEF by measuring the left ventricular ejection fraction (LVEF) and evidence of structural heart disease and diastolic dysfunction.

Original language	English
Pages (from-to)	1-9
Number of pages	9
Journal	Current Heart Failure Reports
Volume	15
Issue number	1
Early online date	5 Feb 2018
DOIs	https://doi.org/10.1007/s11897-018-0372-1
Publication status	E-pub ahead of print - 5 Feb 2018

Access to Document

10.1007/s11897-018-0372-1Licence: CC BY

The Emerging Role of_WEBB_Publishedonline5February2018_GOLD VoR (CC BY)Final published version, 3.46 MBLicence: CC BY

Cite this

@article{507a95eb90dd4175b9124835b2f98e7c,

title = "The Emerging Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Patients with HFpEF",

abstract = "PURPOSE OF REVIEW: To give an update on the emerging role of cardiac magnetic resonance imaging in the evaluation of patients with heart failure with preserved ejection fraction (HFpEF). This is important as the diagnosis of HFpEF remains challenging and cardiac imaging is pivotal in establishing the function of the heart and whether there is evidence of structural heart disease or diastolic dysfunction. Echocardiography is widely available, although the gold standard in quantifying heart function is cardiac magnetic resonance (CMR) imaging.RECENT FINDINGS: This review includes the recently updated 2016 European Society of Cardiology guidelines on diagnosing HFpEF that define the central role of imaging in identifying patients with HFpEF. Moreover, it includes the pathophysiology in HFpEF, how CMR works, and details current CMR techniques used to assess structural heart disease and diastolic function. Furthermore, it highlights promising research techniques that over the next few years may become more used in identifying these patients. CMR has an emerging role in establishing the diagnosis of HFpEF by measuring the left ventricular ejection fraction (LVEF) and evidence of structural heart disease and diastolic dysfunction.",

author = "Jessica Webb and Lauren Fovargue and Kristin T{\o}ndel and Bradley Porter and Benjamin Sieniewicz and Justin Gould and Rinaldi, {Christopher Aldo} and Tevfik Ismail and Amedeo Chiribiri and Gerald Carr-White",

year = "2018",

month = feb,

day = "5",

doi = "10.1007/s11897-018-0372-1",

language = "English",

volume = "15",

pages = "1--9",

journal = "Current Heart Failure Reports",

publisher = "Current Science, Inc.",

number = "1",

}

TY - JOUR

T1 - The Emerging Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Patients with HFpEF

AU - Webb, Jessica

AU - Fovargue, Lauren

AU - Tøndel, Kristin

AU - Porter, Bradley

AU - Sieniewicz, Benjamin

AU - Gould, Justin

AU - Rinaldi, Christopher Aldo

AU - Ismail, Tevfik

AU - Chiribiri, Amedeo

AU - Carr-White, Gerald

PY - 2018/2/5

Y1 - 2018/2/5

N2 - PURPOSE OF REVIEW: To give an update on the emerging role of cardiac magnetic resonance imaging in the evaluation of patients with heart failure with preserved ejection fraction (HFpEF). This is important as the diagnosis of HFpEF remains challenging and cardiac imaging is pivotal in establishing the function of the heart and whether there is evidence of structural heart disease or diastolic dysfunction. Echocardiography is widely available, although the gold standard in quantifying heart function is cardiac magnetic resonance (CMR) imaging.RECENT FINDINGS: This review includes the recently updated 2016 European Society of Cardiology guidelines on diagnosing HFpEF that define the central role of imaging in identifying patients with HFpEF. Moreover, it includes the pathophysiology in HFpEF, how CMR works, and details current CMR techniques used to assess structural heart disease and diastolic function. Furthermore, it highlights promising research techniques that over the next few years may become more used in identifying these patients. CMR has an emerging role in establishing the diagnosis of HFpEF by measuring the left ventricular ejection fraction (LVEF) and evidence of structural heart disease and diastolic dysfunction.

AB - PURPOSE OF REVIEW: To give an update on the emerging role of cardiac magnetic resonance imaging in the evaluation of patients with heart failure with preserved ejection fraction (HFpEF). This is important as the diagnosis of HFpEF remains challenging and cardiac imaging is pivotal in establishing the function of the heart and whether there is evidence of structural heart disease or diastolic dysfunction. Echocardiography is widely available, although the gold standard in quantifying heart function is cardiac magnetic resonance (CMR) imaging.RECENT FINDINGS: This review includes the recently updated 2016 European Society of Cardiology guidelines on diagnosing HFpEF that define the central role of imaging in identifying patients with HFpEF. Moreover, it includes the pathophysiology in HFpEF, how CMR works, and details current CMR techniques used to assess structural heart disease and diastolic function. Furthermore, it highlights promising research techniques that over the next few years may become more used in identifying these patients. CMR has an emerging role in establishing the diagnosis of HFpEF by measuring the left ventricular ejection fraction (LVEF) and evidence of structural heart disease and diastolic dysfunction.

U2 - 10.1007/s11897-018-0372-1

DO - 10.1007/s11897-018-0372-1

M3 - Review article

C2 - 29404975

VL - 15

SP - 1

EP - 9

JO - Current Heart Failure Reports

JF - Current Heart Failure Reports

IS - 1

ER -

The Emerging Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Patients with HFpEF

Abstract

Access to Document

Fingerprint

Cite this